ArticleData in brief2026
Dataset of RNA-seq profiles from THP-1-derived macrophages pretreated with AZD7648 and stimulated with CT DNA.
Article in Data in brief, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article describes an RNA-seq dataset generated from THP-1-derived macrophages under four treatment conditions: untreated control, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) inhibitor AZD7648 alone, calf thymus DNA (CT DNA) alone, and AZD7648 pretreatment followed by CT DNA stimulation. Each condition included three biological replicates, yielding 12 transcriptome samples in total. Libraries were sequenced on the Illumina NovaSeq 6000 platform using paired-end 150-bp reads. The dataset includes raw sequencing reads, gene-level expression matrices, and associated quality control metrics. All RNA samples exhibited RIN values between 9.5 and 9.9. Clean reads ranged from 54.83 to 70.25 million per sample, with Q30 values of 97.18%-97.34%, total mapping rates of 98.24%-98.51%, and unique mapping rates of 95.55%-95.81%. This dataset provides a resource for comparative transcriptomic analyses of cytosolic DNA stimulation and DNA-PKcs inhibition in macrophage cells and may support reuse in studies of innate immune signaling, cytosolic DNA sensing, and pathway-focused reanalysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.